Strategic B2B Sourcing for Chinese Pharmaceutical Importers & Specialist ENT Hospitals
Sky High Medex is a specialized pharmaceutical exporter providing Gidihist 16 Tablets to licensed medical wholesalers, hospital procurement departments, and specialized ENT (Ear, Nose, and Throat) clinics across China. Manufactured by Lupin Ltd, Gidihist contains Betahistine Dihydrochloride (16mg), a high-quality antivertigo agent utilized for the professional management of Ménière’s disease and vestibular balance disorders.
B2B Order Details:
Minimum Order Quantity (MOQ): 500 Tablets (Strictly Wholesale).
Active Ingredient: Betahistine Dihydrochloride 16mg.
Manufacturer: Lupin Ltd.
Therapeutic Class: Antivertigo; Histamine Analogue.
Format: Tablet.
The Sky High Medex Advantage for the Chinese Market:
Direct Export Economies: Optimize your procurement margins for healthcare networks in Shanghai, Beijing, and Guangzhou by sourcing directly from our Indian wholesale center, offering significant cost-efficiency for high-volume vestibular medications.
Lupin Ltd Quality Assurance: Access a reliable formulation produced by a globally recognized pharmaceutical leader, ensuring the potency, chemical stability, and adherence to international quality standards required for clinical use.
Verified Export Authority: We operate with a valid Import-Export Code (IEC) and GST registration, providing a 100% transparent and professional trade trail for Chinese-based business and medical entities.
Full Documentation Suite: Every shipment includes the Certificate of Analysis (COA), detailed commercial invoices, and packing lists to support institutional auditing and cross-border trade compliance.
Logistics & China Customs Support:
While domestic import licenses and adherence to the National Medical Products Administration (NMPA) guidelines remain the responsibility of the importer, Sky High Medex ensures all Indian export formalities are handled with professional precision. We offer reliable air-freight shipping to major Chinese hubs, including Shanghai Pudong (PVG), Beijing Capital (PEK), and Guangzhou Baiyun (CAN).
Technical Insight & Pharmacological Action:
Gidihist (Betahistine 16mg) is recognized for its targeted action on the microcirculation of the inner ear. In a clinical and research context, it is noted for:
Mechanism of Action: Betahistine acts as a strong $H_3$ receptor antagonist and a weak $H_1$ receptor agonist. It improves blood flow to the stria vascularis and the vestibular system by vasodilating precapillary sphincters, effectively reducing endolymphatic pressure.
Management of Ménière’s Disease: Indicated for the reduction of the frequency and intensity of vertigo attacks, and the management of associated symptoms like tinnitus and progressive hearing loss.
Vestibular Stabilization: Helps stabilize the vestibular system without the sedative effects common in older antivertigo medications, supporting better patient mobility.
Pharmacokinetic Profile: Following oral administration, the active ingredient is rapidly absorbed, reaching peak plasma levels within 1 to 2 hours. It is primarily eliminated through renal excretion.
👉
📦 Request a Wholesale Quote for China
Direct B2B support for China-based pharmaceutical buyers and healthcare distributors.
WhatsApp: +91 9270847472
Email: skyhighmedex@gmail.com
Location: Nagpur Export Hub / International Service Desk
